Navigation Links
Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees
Date:7/24/2009

PRINCETON, N.J., July 24 /PRNewswire/ -- Serious buyers and sellers of leading fine and custom chemical companies from around the world who gather at InformexUSA 2010 will experience even more focused, more efficient networking opportunities than in the past, allowing them to connect more precisely with others in their specific market.

The show opens February 16, 2010 in San Francisco, with a new agenda to reflect a targeted, but separate, focus on pharmaceutical and specialty chemical topics.

"The historic focus of Informex has been fine & specialty chemicals, custom chemical manufacturing, and related chemical materials and services," said Jennifer Jessup, Business Director, Informex.

"Exhibitors and attendees expressed the need for a show format tailored to their specific market; life science applications (pharma, biotech, agro) on the one hand and broader specialty and industrial chemicals, on the other. Our new segmented format is in response to that market need."

Informex Specialty programs will include:

* Specialty R&D Buyer Showcases featuring R&D speakers from key chemical companies.

* Chemical Licensing Breakfast Briefing presented by the Licensing Executives Society (LES).

* Green Chemistry Exchange showcasing sustainable and green chemistry products, technologies and services.

* Green Chemistry Breakfast Briefing developed in partnership with the ACS Green Chemistry Institute.

* Specialty Chemical Pavilion featuring companies serving the specialty and industrial chemical markets.

Informex Pharma programs will include:

* API Pavilion displaying Active Pharmaceutical Ingredient companies who service both generic and branded pharmaceuticals.

* Pharma Buyer Showcases to allow exhibitors to hear what their customers are looking for.

"We are happy to see Informex making a conscious effort to focus on specialty chemicals and getting back to the roots of the show. This is an under-represented market in US tradeshows and one we are happy to help grow,"

said Slaton Fry, Director at FutureFuel Chemical Company.

Informex is committed to providing the most valuable trade show for the fine and custom chemical industry and will continue to evaluate the current needs and wants of its exhibitors and attendees.

For more information on the upcoming show, please visit www.informex.com, or call Tom Leahy at 609-759-4731 or Devin Hader at 609-759-4746.

About Informex:

Organized by UBM International Media, Informex is the leading meeting place for buyers and sellers of high-value chemistry for a broad range of applications. As the leading fine chemical tradeshow in the United States, InformexUSA has been a marketplace for networking and doing business in the fine, custom and specialty chemical manufacturing industry for more than 25 years. Visitors to the show come from a broad range of manufacturing industries including adhesives, electronics, agrochemicals, biopharmaceuticals, pharmaceuticals, plastics, paints, and more. Each year the event brings together an international mix of more than 4,000 fine and specialty chemicals professionals and 500 exhibitors. For more information, visit www.informex.com

About UBM International Media (UBMi):

UBMi is a wholly owned subsidiary of United Business Media plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.unitedbusinessmedia.com


'/>"/>
SOURCE Informex
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Informex365.com is Launched for Manufacturers in Search of Chemical Reactions Expertise
2. Informex Opens Registration to InformexUSA 2009
3. InformexUSA 2009 Opens to Strong Attendance
4. Informex Survey Shows Innovation Remains a Priority for 2009 and Beyond
5. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
6. Angiotech to Establish Separate Operating and Royalty Businesses
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... -- Four US Biotech equities have been ... are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), Arrowhead Pharmaceuticals Inc. ... and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ). ... are growing more bullish on the sector as a ... cash held overseas for tax reason by large US ...
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... SAN FRANCISCO, CA (PRWEB) , ... February 24, 2017 , ... ... awarding of a $224K grant from the National Institute of Mental Health (NIMH) for ... is based on Delpor’s PROZOR technology and is expected to deliver therapeutic ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:2/1/2017)... 1, 2017 IDTechEx Research, a leading provider ... announces the availability of a new report, Sensors for Robotics: ... Continue Reading ... ... robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts ...
Breaking Biology News(10 mins):